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Background: Although it is widely accepted that serotonin plays a pivotal role in emotional 
perception and processing, the role of serotonin in cognition is less clear. The present study 
investigated the implications of introducing emotional faces in a measure of cognitive control 
functioning. The measure was explored in association with the serotonin transporter 
polymorphism (5-HTTLPR), linked to serotonin transmission in the brain. An integrative 
model of emotional processing was used to illustrate cognitive control functioning in 
emotional processing and potential 5-HTTLPR-dependent diatheses for depressive 
symptomatology. As previous studies have shown the effect of sex on the relationship 
between 5-HTTLPR subtypes and cognitive measures, we also included sex as a variable in 
our analyses.  
 
Methods: Sixty healthy participants were recruited in an experimental design. The 
participants underwent an extensive screening procedure and gave blood samples for 5-
HTTLPR analysis. A new computerized test, labeled the Emo n-back, was constructed to 
explore the implications of presenting emotional categories of human faces in a paradigm 
measuring aspects of cognitive control functioning. Emotional categories within the Emo n-
back were analyzed to spot 5-HTTLPR-dependent variation in cognitive and emotional 
perception and processing in males and females.  
 
Results: Exposure to different emotional categories had specific effects on cognitive control 
functions as measured by the Emo n-back. Participants showed significantly decreased 
accuracy on the n-back task when presented with successive images from the negative 
emotional categories, and this effect was most pronounced for sad compared with neutral 
faces. A three-way interaction effect was found between sex, 5-HTTLPR polymorphism and 
emotional categories within the Emo n-back. Examination of this interaction revealed a 
distinct pattern for female short 5-HTTLPR carriers indicating an increased sensitivity to the 
sad emotional category in this subgroup of participants.    
 
Conclusion: Sex and 5-HTTLPR polymorphism had a significant impact on accuracy in a 
measure of cognitive control function. The effect is most pronounced when presented with 
sad human faces, indicating altered sex- 5-HTTLPR-dependent processing linked to specific 
emotional content. The Emo n-back indicated mechanisms that might represent diatheses for 
depressive symptomatology by demonstrating the different genotypes to reveal distinct 
patterns in the way they process adverse environmental stimuli. 
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Introduction 
An important approach to the study of mood and cognition has been to consider the genetic, 
neural, neurochemical and neuropsychological substrates of mental illness. Studies in this area 
have uncovered important aspects of diathesis, development, symptoms and recovery of 
psychological disease. The studies also contribute to the development of global structures of 
emotion and normal emotional perception and processing. Integrating global constructs of 
emotion and specific objective measurable constituents represents a bridging in the literature 
on both normal emotional processing and disorders of emotion.  
 
The mapping of the human genome has enabled explorations of the specific genetic 
contributions to neural structures and neurochemistry, as well as the associated emotional and 
cognitive derivates.  
 
Looking for biological markers associated with specific genes amounts to the study of 
endophenotypes. Most current studies on endophenotypes have used different neuroimaging 
procedures, such as measures of neural activation of specific brain regions. In contrast, the 
strategy of mapping the genes’ cognitive architecture is in its infancy and is often even 
neglected. This is probably based on the assumption that the endophenotypes convey a 
simpler architecture and may be closer to the level at which genes operates than more remote 
phenotypes (Meyer-Lindenberg & Weinberger, 2006). This assumption probably holds for 
measures based on self reports, life stories or clinical symptoms, although this view has also 
been contested based on reliability analysis (Flint & Munafò, 2007). The use of objective 
neuropsychological measures represents a promising contribution to the understanding of 
genes’ phenotypic expression. Furthermore, exploring psychological resolution in cognitive 
processes may contingently help us to delimit 5-HTTLPR-associated phenotypes that 
otherwise would be overlooked based on neuroimaging studies alone.  
 
The neuropsychological picture is broadly addressed in studies of cognitive deficits associated 
with the symptomatology of major depression, but is sparse in studies investigating the 
potential gene candidates that we know are involved in cognitive and emotional processing 
involved in the same phenomena. This paper will address this view by showing that 
hypotheses based on neuropsychological data constitute a major contribution to the 
understanding of genes phenotypic expression. The focus will be on serotonin (5-HT) 
functioning and a polymorphic genetic region linked to the transcription of a reuptake protein 
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central to serotonin metabolism (5-HTTLPR within the transcriptional region SLC6A4). The 
objective of this study was to supplement existing studies by constructing an objective 
cognitive paradigm able to spot subprocesses in cognitive and emotional processing. 
 
It’s important to bear in mind that causes of mental illness are complex, and interact and vary 
according to the particular disorder and individual. Genetics, early development, disease or 
injury, neurocognitive and psychological mechanisms, life experiences, society and culture 
can all contribute to the development or progression of different metal disorders. The 
serotonin-linked polymorphism will represent a relatively small effect against a background 
of substantial genetic and environmental variation. 
 
Context 
The rationale for choosing the serotonin system and the associated polymorphic region (5-
HTTLPR) as the most central gene candidate mainly comes from two sources. The first comes 
from pharmacological studies of, and treatment with, serotonin-linked antidepressants. The 
other comes from neuroscience and studies that show considerable overlap between abnormal 
brain structure and functioning in major depression and serotonergic circuits.  
 
The serotonin system is a common target for antidepressants, anxiolytics and antipsychotic 
drugs. Serotonin controls neural specificity, differentiation and phenotypic duration of various 
mental disorders. The formation and integration of neural networks depends on processes tied 
to several proteins, but a string of studies indicates that variability in the expression of the 
serotonintransporter (5-HTT) is critical for development and plasticity in delimited neural 
pathways (Lesch & Gutknecht, 2005).  
 
Serotonin controls a highly complex system of neural communication circuits mediated by 
several pre- and postsynaptic subgroups of 5-HT receptors. A frequent transport of 5-HT in 
the presynaptic neuron, that leads to the maintenance of 5-HT and further release in the 
synaptic gap, is mediated by a unique protein. This protein, the 5-HT transporter, 5-HTT, is 
the functional site of antidepressants, like prototypical tricyclic clomipramine and, in 
particular, for the group labelled “selective serotonin reuptake inhibitors” (SSRIs), like 
fluvoxamine, paroxetine, citalopram and sertaline. The different subgroups of SSRIs don’t 
share identical pharmacokinetic functioning but are all linked to the 5-HT transporter. These 
drugs are in frequent use for the treatment of depression, anxiety and disorders associated 
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with impulsivity, like obsessive-compulsive disorder (Lesch & Murphy, 2003), as well as 
several potential neurotoxin preparates like MDMA (ecstasy). 
 
Until recently, focus has been on kinetic variability (what the body does to the drug) while 
dynamic variability (what the drug does to the body) has obtained less attention. However, it 
now seems that pharmacodynamic variability in humans is large, reproducible and usually 
more pronounced than pharmacokinetic variability. Many drug targets, like receptors, 
transporters and enzymes, don’t only contribute to the regulation of the transmitter system but 
also, directly or indirectly, modulate the plasticity of neurocircuits. Both variation in structure 
and variation in expression influence the gene product, availability and function. This will 
have a substantial influence on further functioning and efficacy in a dynamical manner.  
 
When we know there is a genetic polymorphism that has a major influence on kinetic 
serotonin functioning, the same polymorphism should have neuroanatomical and cognitive 
derivates based on dynamical developmental variability. Mood, cognition and motor 
functioning, as well as circadian and neuroendocrine rhythms, are all modulated by the 
brainstem serotonin system and distinctively altered in anxiety and affective disorders. This 
variability should be uncovered and checked in relation to the current gene candidate. 
Different methods are required to explore variability both within and between the different 
serotonin-modulated functions.  
 
Contemporary literature on depressive disorders is massive on both functional and structural 
aspects. Even mild depression is associated with pronounced deficits in cognitive, emotional, 
motor, perceptual and communication tasks. Wide-ranging neuropsychological deficits in 
depressed patients are found in areas like executive function (Elliot, 1998; Murphy et al., 
2001; Landrø, Stiles & Sletvold, 2001), identification of emotionally significant stimuli 
(Rubinow & Post, 1992), negative emotional bias (Bradley, Mogg & Millar, 1996; Murphy et 
al., 1999; Williams, Mathews & Macleod, 1996) and negative, or reduced, positive attention 
bias while identifying emotional expressions of human faces (David & Cutting, 1990; Gur et 
al., 1992; Surguladze et al., 2004).   
 
Structural abnormalities are found in several areas associated with the processing of 
emotional stimuli. The most consistent findings involve the amygdala (Sheline et al., 1998; 
Bowley et al., 2002), subgenual region of the anterior cingulated gyrus (Drevets et al., 1997; 
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Cotter et al., 2001; Botteron et al., 2002), prefrontal cortical regions (Coffey et al., 1993; 
Goodwin et al., 1997; Ongur et al., 1998; Rajkowska et al., 1999, 2001), including the 
orbitofrontal cortex (Bremner et al., 2000) and the hippocampus (Sheline et al., 1999; 
Bremner et al., 2000). Others report volumetric reductions involving the putamen (Husain et 
al., 1991), caudate nucleus (Krishnan et al., 1992) and entorhinal cortex (Bernstein et al., 
1998). Discrepant findings of no significant volume reduction in the hippocampus and 
amygdala (Pantel et al., 1997; Ashtari et al., 1999) and striatal structures (Lenze & Sheline, 
1999) are also reported.  
 
Studies based on functional brain imaging often associate major depression with increased 
blood flow and metabolism within the amygdala (Drevets et al., 1992). Increased blood flow 
within the ventrolateral prefrontal cortex, cingulated cortex, orbitofrontal cortex, ventrolateral 
prefrontal cortex, thalamus and insula are also reported (Drevets, 2003). Amygdala activation 
reveals a positive correlation with depression severity and duration (Drevets et al., 1992; 
Abercrombie et al., 1998). Others report reduced blood flow within ventral limbic regions and 
the ventral striatum (Mayberg et al., 1999) and reduced blood flow in the dorsomedial and 
dorsolateral prefrontal cortex (Baxter et al., 1989; Bench et al., 1993; Buchsbaum et al., 1997; 
Soares & Mann, 1997).  
 
What make these structural and functional imaging findings particularly interesting are that 
many of the same structures listed are often traced as endophenotypes in 5-HTTLPR variation 
and are under considerable serotonergic control.  
 
Importantly, most imaging studies in patients with major depression have either investigated 
only one sex, most frequently females, or have not analysed sex differences (Yurgelun-Todd, 
Sava & Dahlgren, 2007). Sex effects are common in genetic, neural, neurochemical and 
neuropsychological substrates of mental illness (Cosgrove, Mazure & Staley, 2007). 
Depression is also more common in females than in males (Piccinelli & Wilkinson, 2000). 
 
One of the major concerns in genetic studies is that the expected contribution from one single 
gene to explain brain activation or measures of behaviour has to be moderate or minimal, 
given the explained dynamical interaction between genes and environmental factors. These 
can be additive, nonadditive or synergic gene and environment effects and can be difficult to 
uncover. An example is that the magnitude of any association between the 5-HTTLPR and 5-
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HTT functioning may be affected by other polymorphisms within the same transcriptional 
region (SLC6A4) as the 5-HTTLPR, which have the potential to moderate the effects of the 5-
HTTLPR on gene expression and subsequent biological processes potentially sensitive to 
alterations in serotonin neurotransmission. This means that factors closely linked to the 
polymorphic region probably mediate functional variability even before we consider 
endophenotypes or cognitive phenotypes. Global measures of brain structures, brain activity, 
personality traits or symptoms run the risk of conveying unsubtle measures by neglecting the 
impact of sex, actual symptomatology or the quality and specificity of the inventories.  
 
The expected small gene effect against a background of substantial genetic and environmental 
variation represents serious challenges when modelling neuropsychological functional studies. 
Modelling requires, more than usual, measures of specific subprocesses to avoid irrelevant 
factors that complicate the study or extinguish an actual effect. Many studies try to 
compensate for this problem by considering several gene candidates and behavioural 
measures to explore interactions between them. As we will see, many of the most cited studies 
on the field have this objective and conclude with interaction effects. One major concern is 
that potentially relevant candidate variables and their interaction over time are almost infinite.  
 
Serotonin in the Brain 
The brain’s serotonin activity is, as we have seen, regulated by the serotonin transporter 5-
HTT. The 5-HTT is a sodium chlorine-dependent transporter located in the plasma 
membrane of the cell. When serotonin is released in the synaptic gap the presynaptically 
located 5-HTT will return serotonin to the cell for recycling and metabolic decomposition. 
The other monoamines are mediated by the serotonin transporter and the same functional 
principle holds for other monoamines, like dopamine, norephineprine, epinephrine, 
melatonin, histamine and thyronamines and their respective reuptake transporters.  
   
Under normal physiological circumstances, the 5-HTT’s major purpose is the efficient 
removal of serotonin from extracellular areas. Abnormal or manipulated functioning will alter 
the duration and intensity of 5-HT communication with its receptors and postsynaptic targets 
located in limbic structures, mediating emotional processing, or presynaptic receptors with 
inhibitory control of the 5-HT neuron itself (Fig. 1). 
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Figure 1 Illustration of the 5-HTT’s role in human serotonin metabolism.  
A: When 5-HT is released in the synaptic gap, 5-HT returns to the presynaptic neuron through 5-HTT reuptake. 
This makes the 5-HTT significant for the duration and intensity of 5-HT’s communication with postsynaptic 
targets.  
B: The effect of low 5-HTT activity leads to downregulated presynaptic activity, but upregulation of several 
postsynaptic targets. Presynaptic receptors, on top and towards soma of the presynaptic neuron, represent 
inhibitory control of the neuron itself. 
 
As we can see from the principal model, decreased 5-HTT gene function increases serotonin 
levels and leads to reduced receptor binding to receptors 5-HT1A and 5-HT1B, but increased 
5-HT2A, 5-HT2C and 5-HT3 receptor mRNA levels and/or ligand binding. This means that 
5-HTT function has both excitatory and inhibitory effect on the postsynaptic cell. Seven 
distinct families of 5-HT receptors have been identified (5-HT1–5HT7), and subpopulations 
have been described for several of these (at least 15 subpopulations). If we imagine that the 
presynaptic cell is a raphe nucleus efferent and the postsynaptic cell is coupled to limbic 
structures involved in mood regulation, the net effect is best understood as a spectrum of 
different variants rather than one functional and one dysfunctional variant. This highlights the 
complex dynamical interaction between gene transcription, neurochemical processes and 
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neural development and will be of substantial interest in exploring the gene-linked phenotypic 
variants.  
 
When it comes to the net effect of this complex process, a lot remains unclear, but a 
considerable quantity of studies conclude with variation in emotional processing associated 
with decreased 5-HTT functioning in carriers of the genetic type denoted “short variants”  
compared with ”long variants”. The first findings that pointed in this direction were the 
studies that found that unmedicated patients with mood and anxiety disorders had 
significantly reduced 5-HTT binding compared with healthy controls (Malison et al., 1998; 
Arango et al., 2001). Subsequently, pharmacological findings indicated associations between 
response time and total response to SSRIs and the short 5-HTTLPR variants among patients 
with depressive disorders. This means that the same amount of drugs have different force 
depending on one single polymorphic region (Lesch & Gutknecht, 2005). 
 
A growing number of studies conclude with 5-HTTLPR-dependent allelic variation in 5-HTT 
expression and brain functions in anxiety and depression, but also in conditions associated 
with aggression and other psychological disorders. The most consistent findings are found 
within disorders with a considerable affective symptomatology, like depression, bipolar 
disorder, anxious personality disorders (cluster C), eating disorders, substance-related 
disorders and neurodegenerative disorders (Lesch & Mössner, 1998). Increased 5-HTT 
function is seen in ADHD, obsessive-compulsive disorder and autism. The latter is based on 
overrepresentation of the long polymorphic variant in people with these constellations of 
symptomatology (Lesch & Murphy, 2003). The findings indicate both short and long variants 
to represent diatheses and that operating with a short dysfunctional variant and a long 
functional variant may be an erroneous simplification.  
 
Genetic Variability in Serotonin Transporter Functioning 
In humans, transcriptional activity of the 5-HT transporter gene SLC6A4 is modulated by the 
polymorphic repetitive element (5-HTT gene-linked polymorphic region, 5-HTTLPR) located 
upstream on the transcriptional start site. The majority of alleles consist of 14 or 16 repetitive 
elements that correspond to the division of, respectively, short and long variants. Repetitions 
of 15, 18-20 or 22, plus some other variants, occur but are rare. Alleles and genotypic 
distributions have substantial variations across different populations (Lesch & Gutknecht, 
2005). 
  12
The different 5-HTTLPR variants form bases for the formation of a second DNA structure 
that has the potential to regulate transcriptional activity in the associated 5-HTT gene 
promoter. A promoter is the part of the DNA molecule that contributes to the regulation of 
gene expression. Expression depends on the kinds of transcriptional factors that are connected 
to the gene in the particular case. Transcriptional activity in the 5-HTT gene promoter is 
mediated by the presentation of short or long 5-HTTLPR variants (Lesch et al., 1996). 
 
The transcriptional factor has at least two different effects on the gene product, one connected 
with DNA binding and another that provides gene activation (Fig. 2). The transcriptional 
factor’s main function is to turn on and off other genes. For this purpose, they have to form a 
complex with other proteins and bind to the start site to turn on the process that copies the 
gene by the enzyme RNA-polymerase.   
 
 
 
Figure 2 gives a schematic illustration of central transcriptional factors. The line on top shows the two main 
elements in a transcriptional factor: one element that has the capability to bind to DNA and another element that 
stands for the transcriptional activation or turning on or off of other genes. The illustration shows the 
transcriptional factor that, to accomplish its function, binds to other factors to form a complex. This complex 
usually connects to a binding site upstream of the gene’s start site. When the complex is on-site, the gene turns 
on and is copied by the enzyme RNA-polymerase. 
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As we have seen, the 5-HTT gene promoter contains special sequences recognized by proteins 
called transcriptional factors. In eukaryotes (cells with soma), we know seven such factors. 
This again accents the complicated biochemical connections in the transcriptional process 
where the described polymorphic region constitutes a restricted component. The genetic 
sequence we study is a component that modulates the effect of the DNA promoter and that 
will determine the quantity and activity of the reuptake protein 5-HTT. 
 
The link between variations in 5-HTTLPR length and 5-HTT function is studied by looking at 
the 5-HTTLPR genotype, 5-HTT gene transcription and 5-HT reuptake activity in human 
lymphoblast cell lines (lymphoblast cell lines are precursors of lymphocytes that constitute 
one-quarter of the white blood cells). Cells homozygous for the long variant produce higher 
concentrations of 5-HTT mRNA compared with cells with one or two copies of the short 
variant. This means that both the quantity of the 5-HTT protein and the activity in this channel 
linked to 5-HTTLPR variation can be detected. Similar findings are reported in studies 
investigating other cell lines (Mortensen et al., 1999) and by using several other procedures 
(Lesch & Gutknecht, 2005).  
 
When 5-HTTLPR variants melt together with a luciferase reporting gene and are transported 
into human cell lines, they modulate the transcriptional activity of the 5-HTT gene promoter 
(Lesch et al., 1996). Luciferase is an enzyme that gives off light by oxidation of the chemical 
substrate luciferin. Thus, the amount of light indicates transcriptional activity, and in this way 
the transcriptional activity in living cells can be measured. This means seeing genetic 
modulation effects in real time, and not only in association with 5-HTT activity or density. 
This is an important finding consolidating the assumption that there exists an actual causal 
link between the 5-HTTLPR and serotonin function. It also shows that we, already at this 
early level in the space between 5-HTTLPR and 5-HT functioning have started the motion 
from the level on which genes operates, and that further analyses on higher levels will be 
prone to effects and interactions caused by factors in these processes.  
 
Several algorithms are developed to facilitate uncovering of promoters in genetic sequences. 
The uncovering of promoters is common in many methods developed for predicting genetic 
expression. Current technologies can, by using data technology, mathematics, biochemistry 
and statistics, uncover the functional 5-HTTLPR variants and divide the three categories 
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based on the pairing of short and long variants (long/long, short/short and long/short). These 
two original variants (long and short) have been studied intensively. Recently, functional 
variants were identified within the long variant, designated LA and LG variants, representing a 
single nucleotide polymorphism. Based on such findings, suggestions have been put forward 
that this is really a three allelic functional polymorphism (Hu et al., 2006). The LG and S 
alleles have comparable levels of 5-HTT transporter expression, and both are lower than that 
of the LA allele (Hu et al., 2006). However, this finding has not been consistently replicated 
(Martin et al., 2007). Furthermore, Wendland et al. (2006) have demonstrated that the single 
nucleotide polymorphism can be associated with either long or short variants. Thus, hesitancy 
in the division of genetic categories typifies fundamental challenges in present studies of 5-
HTTLPR variability.  
 
Serotonin Circuits 
Serotonin-containing neurons are mainly collected in the nine cores called raphe nuclei. 
Raphe nuclei are groups of neurons in the brainstem’s whole length and are especially centred 
around the reticular formation, one on each side of the brainstem’s midline. Each nucleus has 
projections to particular brain areas and structures. Caudally located nuclei, in the medulla, 
affect processes associated with the spinal cord where they moderate pain-related sensorial 
signals. Rostral nuclei, in the pons and midbrain, affect sweeping areas of the brain in a more 
diffuse manner. Raphe nuclei cells are most active during the conscious awake condition and 
in active high physiological conditions. In addition to the role of these nuclei in emotional 
perception and mood regulation, they are involved in sleep and sleep cycles (Bear, Connors & 
Paradiso, 2001). Present findings suggest that serotonin isn’t transported via terminal buttons, 
as in classic neurotransmission, but by varicosities (swelling) along axons to the extracellular 
space. In this way, by diffusion, serotonin can reach a relatively wide area and activate 
dendrites’ 5-HTT receptors, cell bodies and presynaptic terminals in adjacent neurons.  
 
Serotonin plays an important role in cortical development, shaping neuronal circuitry by 
regulating synaptic plasticity and neuronal activity patterns of serotonergic and non- 
serotonergic neurons (Gaspar et al., 2003). Importantly, serotonin has broad developmental 
effects, promoting differentiation not only of serotonergic but also of glutamatergic neurons, 
which transiently express 5-HTT in limbic regions such as the cingulated cortex. A growing 
amount of evidence indicates 5-HT balance to be crucial for the development, differentiation 
and maturation of nerve cells and networks in brain areas that control sensorial input, stimulus 
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processing and motor response. Examples are that 5-HT modulates projections from the cell 
bodies of thalamocortical glutaminergic neurons in cultures that involve serotonin receptors, 
the 5-HT contributes to differentiation of cortical glutaminergic neurons via one of the 5-HT 
receptor subgroups (Lieske et al., 1999), the accession of 5-HT increases the likelihood for 
long-term potential in the visual cortex (Kojic et al., 2000). In mice, chronic treatment with 
antidepressants affects the birth of new nerve cells in the hippocampus (Santarelli et al., 
2003). This and similar findings accent the importance of a developmental, dynamical 
perspective when accomplishing studies on 5-HTTLPR variability. Research on how gene-
gene and gene-environment interactions affect the development, plasticity and formation of 
synaptic connections during childhood, adult life and ageing is only in its early beginnings.   
  
Sex Differences Associated with the 5-HTTLPR Genotype 
Recently, sex has attracted substantial attention when examining 5-HTTLPR variability. 
There is a wealth of preclinical and clinical evidence supporting sex differences in serotonin 
neurotransmission (Fink et al., 1998). Consideration of sex has varied markedly across 
studies. Some have failed to address specifically sex differences by using sex as a covariate, 
matching groups, exclusively including male or female participants or by no consideration of 
potential sex effects. Brummett et al. (2007) have recently demonstrated that, in females, 
homozygote short variants are associated with susceptibility to depression under stressful life 
conditions, whereas the homozygote long variants do so in males, revealing an opposite 
genotype-environment pattern in males and females. Eley et al. (2004) and Sjöberg (2006) 
showed an interaction in the expected direction for females only and a trend for an opposite 
effect in males. When positive results have been reported separately for both sexes, the gene- 
environment effect has shown to be stronger among females (Kendler et al., 2005). The 
implication of sex could also be age-specific or stronger among specific age cohorts (Uher & 
McGuffin, 2008). The studies posit the importance of the use of sex as a grouping variable to 
spot specific sex effects.  
 
Neurocognitive Functions Associated with the 5-HTTLPR Genotype  
Genotype-phenotype correlations are seen by using functional neuroimaging procedures like 
ERP (event-related potentials), fMRI (functional magnetic resonance imaging), perfusion MR 
and PET (positron emission tomography) and compose the majority of studies on 5-HTTLPR 
variation. Falgatter et al. (1999, 2004) reported associations between the 5-HTTLPR genotype 
and prefrontal cortex-limbic excitability by using tasks that involve cognitive response control 
  16
(Go-NoGo and error-processing tasks) in healthy volunteers without known symptomatology. 
Participants with one or two short variants in 5-HTTLPR showed higher prefrontal ERP 
activity compared with subjects homozygous for the long variant. The findings indicate an 
increased response in the prefrontal cortex, especially the anterior cingulated cortex (ACC).  
 
Hariri et al. (2002) have shown that participants with at least one copy of the short variant 
have a higher amygdala response, examined by fMRI, when introduced fo potential fright- 
evoking stimuli compared with subjects homozygous for the long variant. This indicates that 
differences in amygdala excitability, when presented with potentially emotionally significant 
stimuli, contribute to fear- and anxiety-related responses. After these early studies, the topic 
was considerably elaborated and widely published, showing associations between the 
polymorphic region and amygdala activation. A meta-analysis by Munafò, Brown and Hariri 
(In Press) concludes that 5-HTTLPR polymorphism accounts for up to 10% of phenotypic 
variance when reanalysing data from fourteen studies using fMRI, PET and perfusion MR. 
They also included unpublished data sets to avoid possible publication bias. The results 
indicate that alternations in 5-HT signalling associated with the 5-HTTLPR appear to 
contribute significantly to amygdala activation in response to a broad range of salient 
environmental stimuli. The studies never compare or separate the different categories of 
negative emotional stimuli.  
 
Functional neuroimaging has revealed increased blood flow and brain activation in healthy 
controls within the amygdala when presenting unfamiliar faces (DuBois et al., 1999). Similar 
findings are seen when participants are shown fearful (Breiter et al., 1996; Morris et al., 1996; 
Phillips et al., 1997, 2001; Wright et al., 2001), sad (Blair et al., 1999) and happy (Breiter et 
al., 1996) faces. Amygdala activation is also seen in response to several other potential 
emotionally significant stimuli linked to different sensorial modalities. Taken together, the 
findings indicate that the amygdala plays a decisive role in the modulation, vigilance and 
attention to emotionally significant information (Davis & Whalen, 2001). The findings further 
suggest human faces as one of the potentially most successful stimuli for amygdala activation. 
Importantly, the amygdala is not activated only when presented with negative stimuli but also 
when presented with positive emotional stimuli.  
 
Recently, Beevers et al. (2007) have reported 5-HTTLPR-dependent attention bias in a 
psychiatric inpatient group using a standard dot-probe reaction time task. Participants 
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homozygous for the long 5-HTTLPR variants had a stronger attention bias for anxious word 
stimuli compared with participants carrying one or two copies of the short 5-HTTLPR 
variants. The attention bias was not found when presented with dysphoric word stimuli. The 
study indicates an association between 5-HTTLPR variants and biased attention, not only 
indicated by amygdala activation, but also when measured with a behavioural reaction time 
task.  
 
The amygdala is a complex of nuclei and afferents to the amygdala come from a large variety 
of sources, including the neocortex, in all lobes of the brain, and the hippocampal and 
cingulated gyri. All sensory systems feed into the amygdala and each sensory system has 
different projection patterns to the amygdala nuclei. Interconnections within the amygdala 
allow the integration from different sensory systems. As a whole unit, the amygdala’s main 
function is the production of an affective state, but it’s still possible that different emotions 
use different amygdala circuits. Given the interconnection with other areas in the brain, 5-
HTTLPR-depended altered amygdala activation probably has implications for different 
aspects of information processing that are not limited to emotional processing. The reviewed 
studies demonstrate increased amygdala activation in carriers of one or two short 5-HTTLPR 
variants compared with homozygote long variants. The comparison indicate that the 
heterozygote 5-HTTLPR variants do not constitute a qualitatively distinct variant but will 
have functional qualities lying somewhere between the two homozygote variants. Higher 
resolution in cognitive measures will contribute to the clarity in functional aspects of 
heterozygote 5-HTTLPR variants.  
 
Traits and Symptomatology Associated with the 5-HTTLPR Genotype  
When they first spotted associations between 5-HTTLPR and its role in the brain’s serotonin 
function, Lesch and his collaborators (1996) reported that individuals carrying short variants 
show increased trait anxiety, particularly neuroticism and harm avoidance, compared with 
individuals homozygous for the long variant. Neuroticism is related to anxiety, stress 
reactivity and depression. The association between the short variants and several measures on 
fear- and anxiety-related traits is replicated in a substantial number of studies and is also the 
conclusion from three independent meta-analyses (Schinka et al,. 2004; Sen et al., 2004; 
Munafò et al., 2005). In contrast to these apparently robust findings, one study with more than 
one hundred thousand participants found no significant associations between 5-HTTLPR and 
neuroticism, as measured using the Eysenck Personality Questionnaire (EPQ) or DSM-IV 
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major depression based on extreme scores of neuroticism (Willis-Owen et al., 2005). The 
authors suggest that 5-HTT function contributes less to an anxious phenotype in extreme 
scores. This and other inconsistent findings highlight the pronounced challenges when 
studying single-gene contributions to polygenetic phenomena interacting with different 
environmental factors. Small sample sizes, heterogeneous subject populations, differing 
methods of personality assessment, selection of extreme scores and abstruse division of 
genotypes may also contribute to the diversity in these findings.  
 
Meta-analytic approaches might have helped in clarifying the data but have also produced 
ambiguous outcomes. Some studies conclude with an association between 5-HTTLPR and 
neuroticism but not with harm avoidance, whereas others report the opposite pattern (Canli & 
Lesch, 2007). One major concern is based on differences in the approach to statistical analysis 
as different analyses have been shown to reveal opposite conclusions.  
 
Animal and human studies also conclude that relatively decreased 5-HTT function isn’t only 
linked to higher anxiety levels, but also has a negative impact on the capability to cope with 
stress. One of the most cited studies on these topics concludes that individuals with short 5-
HTTLPR variants were more often diagnosed with major depression, had higher subjective 
ratings of depressive symptomatology, were rated higher on informant reports of depression 
and had more suicide ideation and attempts. Importantly, however, this association was only 
present or stronger among individuals who had experienced several traumatic life stressors, 
assessed as the number of stressful life events at age twenty-one to twenty-six (Caspi et al., 
2003). They also reported interactions between genotype and maltreatment during the first 
decade of life, assessed as maltreatment between the ages of three and eleven. The study 
provides evidence for a gene-environment interaction, in which an individual’s response to 
environmental insults is moderated by the person’s genetic make-up. 
 
It is important to note that this result does not in itself constitute unambiguous evidence of a 
gene-environment interaction, because exposure to life events may be influenced by genetic 
factors like a heritable tendency to enter situations in which they encounter stressful life 
events in the form of genes not considered. Again, we meet the huge challenges in studies 
trying to uncover contributions from genes and the environment. As was done in the cited 
study, it is important to include cause-order analysis in order to decide on causality in human 
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development. Other gene candidates that share variance with the 5-HTT genotype can also 
make other explanations - not directly associated with serotonin - plausible.  
 
Eley (2004), Kaufman (2004) and Kendler et al. (2005) broadly confirmed Caspi et al.’s 
(2003) study, using different measures of stressful life events and different analytic methods, 
and conclude with a relatively increased risk of depression in the context of environmental 
adversity. After these studies, an additional fourteen similar studies have been published, with 
all but three studies concluding with gene-environment interaction effects (Uher & McGuffin, 
2008). 
 
The specific contribution of one single gene is difficult to uncover but the studies represent 
solid evidence indicating that stress increases the risk of emotional disorders, and that this 
vulnerability is under considerable genetic influence. Several brain structures and functional 
systems are assumedly involved in complex dynamical interaction and transaction processes.  
 
Studies exploring endophenotypes, such as functional measures of neural activation, represent 
a promising bridging of the gap between variants with small effects and complex behaviour 
associated with traits and symptoms. Canli et al. (2006) found interactions between 5-
HTTLPR and life stress on amygdala activation and connectivity, using fMRI and perfusion 
imaging, indicating differences in the amygdala resting state. The stress depression hypothesis 
was further supported by 5-HTTLPR-dependent hippocampus activation and connectivity. 
Interconnections between amygdala and hippocampus are important in stress regulation and 
coping (Bear, Connors & Paradiso, 2001). Frodl et al. (In Press) have recently reported 
reduced hippocampal volume associated with long variants in patients with major depression 
using both the traditional diallelic and the triallelic 5-HTTLPR classifications. The study 
indicates homozygote long carriers’ vulnerability to hippocampal changes.  
 
Other studies have shown that when depression is clinically manifested the short variants are 
associated with more severe symptomatology and a worse prognosis, including a lower effect 
of treatment with antidepressants (Hariri and Holmes, 2006). The question of causality still 
remains. The clinical patients could have diatheses that contribute to inferior coping and 
worse symptomatology and the short variants could make the antidepressants less potent due 
to pharmacokinetic and pharmacodynamic factors. Nonetheless, it is becoming increasingly 
clear that even common variations in genetic sequence impact on function and contribute to 
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measurable variances to this complex phenomena, not only of the transcend 
phenomenological diagnosis, but may also represent the ultimate mechanisms of disease. The 
studies demonstrate 5-HTTLPR variation in both endophenotypes and more remote measures 
of traits and symptomatology.   
 
Conceptual Framework 
Traditionally, the circuits and concepts designated “the limbic system” have been central to 
understanding different aspects of emotion. The limbic system as a concept was suggested by 
Paul Broca as early as the eighteen-seventies, but was at that time associated with olfactory 
perception. Later, the limbic system was used to describe a group of medially located brain 
structures representing a connection between the neocortex and hypothalamus into a 
functional system. As the American neurologist James Papez presented this system in the 
nineteen-thirties, the emotions were regulated by the activity in the anterior cingulated cortex 
and - but in a less direct manner - other cortical areas. Papez postulated that the emotional 
expression is governed by the hypothalamus. The cingulated cortex has projections to the 
hippocampus and projections to the hypothalamus via a bundle of neurons called the fornix. 
Further, the signal reaches the neocortex via the anterior thalamic nucleus. The hypothalamus 
and neocortex are therefore arranged as a reciprocal influence system. Anatomical studies 
verify the existence of the system, but the functional connection to different aspects of 
emotional perception and processing remains speculative. Contemporary neuroscience still 
includes some of the main aspects of these early concepts by Broca and Papez.  
 
One of the major challenges lies in the construction of a system. Many structures and cells 
have several functions and make it difficult to operate with delimited systems. Emotional 
identification and further processing are dependent on components not only associated with 
emotional processing, and sometimes on structures traditionally linked to other cognitive 
processes. Several neuropsychological subprocesses are involved in many different aspects of 
behaviour and make concepts based on delimited systems erroneous. An integrative model 
will illustrate important structures involved in, but not always delimited to, emotional 
perception and processing.  
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An Integrative Model of Emotional Processing 
Phillips et al. (2003) operate with three processes central to emotional perception. The 
processes are linked to different brain structures and functional systems. The first process 
concerns the identification of the stimulus’ emotional significance, the second is about the 
production of the affective state and automatic regulation, and the last process is the one 
where the affective state is further regulated. A ventral system involving the amygdala, insula, 
ventral striatum and ventral areas of the anterior cingulated gyrus and the prefrontal cortex are 
particularly important for processes one and two. A dorsal system including the hippocampus, 
dorsal areas of the anterior cingulated gyrus and prefrontal cortex are central to the regulation 
of the affective state and the following behaviour. Regulation of the affective state and 
emotional behaviour probably involves inhibition, or modulation, of the two other processes 
(Fig. 3). 
 
 
Figure 3 illustrates important functions and structures involved emotional processing. A predominant ventral 
system is central to the identification of the stimulus’ emotional significance, production of the affective state 
and automatic regulation of responses (listed in the grey circle). A predominant dorsal system is central to non- 
automatic regulation of the affective state (white circle on top). Regulation of the affective state and emotional 
behavior probably involves inhibition or modulation of processes 2 and 3 (indicated by curved arrows). VLPFC 
= ventrolateral prefrontal cortex; DLPFC = dorsolateral prefrontal cortex; DMPFC = dorsomedial prefrontal 
cortex; OrbFC = orbitofrontal cortex; ACG = anterior cingulated gyrus.  
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The model shows that the prefrontal cortex plays an important role in emotional perception 
and processing. The prefrontal cortex is the anterior part of the frontal lobes of the brain, lying 
in front of the motor and premotor areas. It can be divided in several ways, which represents a 
huge challenge when reviewing different studies to compare and contrast them. We usually 
roughly separate the orbitofrontal and ventromedial areas, the dorsolateral prefrontal cortex 
and the cingulated cortex. Together, the brain regions have been implicated in planning 
complex cognitive behaviours, personality expression and moderating social behaviour. The 
basic activities are the orchestration of thoughts and actions in accordance with internal goals 
and are often labelled “executive functions” or “cognitive control functions”. Miyake et al. 
(2000) have, by use of factor analysis, presented diversity in executive functioning in three 
factors labelled “mental shifting” (shifting), “information updating and monitoring” 
(updating) and “inhibition of prepotent responses” (inhibition).  
 
Functional brain imaging has, as earlier reviewed, shown that individuals with a major 
depressive episode show increased activation in areas central to the identification of 
emotional stimuli, and for generating emotional behaviour, compared with healthy control 
participants. The structures include the amygdala, orbitofrontal cortex, anterior cingulated, 
ventrolateral prefrontal cortex, anterior insula, ventral striatum and thalamus. The same group 
shows decreased activation in structures central to the regulation of emotional behaviour 
including the dorsomedial and dorsolateral prefrontal cortex. For our purpose, it’s important 
to note that this pattern is reversed in full remission, with increased activation in the 
dorsomedial prefrontal cortex and lower activation in the anterior cingulated, hippocampus, 
thalamus, ventral striatum and insula (Phillips et al., 2003). 
 
Phillips et al. (2003) hypothesize that these processes result in a limited emotional spectrum, 
with a bias towards the perception of negative, before positive, stimuli that results in a 
depressive mood. The structural and functional abnormalities within the dorsolateral and 
dorsomedial cortex, linked to conscious regulation of the affective state, could explain why 
the depression consolidates by shortages in downregulating mechanisms. In healthy control 
participants, we have presented several studies that demonstrate the same structures to be 
linked to 5-HTTLPR variability and serotonin function. Based on these findings, functional 
phenotypic studies should reveal 5-HTTLPR-dependent variability in association with 
negative stimuli.  
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The basolateral amygdala is densely connected with the ventromedial prefrontal cortex, a 
limbic area implicated in the emotional expression. Increased activation in these areas is 
often, but not consistently, observed in major depression (Drevets, 2003). In basolateral 
amygdala, serotonin is thought to modulate incoming projections from the prefrontal cortex 
(Pinto & Sesack, 2003). Heinz et al. (2005) demonstrated 5-HTTLPR-dependent functional 
coupling between the amygdala and the ventromedial prefrontal cortex. The data supports the 
hypothesis that 5-HTT function plays an important role in the development of a negative 
mood state. Dysfunctional amygdala-prefrontal coupling may be associated with 5-HTTLPR-
dependent constraints in the capacity to regulate emotional states. This will enhance the risk 
of clinical depression in these individuals.  
 
Pezawas et al. (2005) demonstrated reduced grey matter volume in short 5-HTTLPR carriers 
in the limbic regions, particularly the perigenual cingulate and amygdala. The perigenual 
cingulate is the phylogentically older archifortical portion of the cingulated cortex and the 
region that displays the highest density of 5-HTT terminals within the human cortex, as well 
as beeing the region that displays the highest target zone of dense projections from the 
amygdala. The feedback coupling between these regions, stimulated by potentially fearful 
stimuli, is implicated in the processing of negative affect. Short 5-HTTLPR carriers show 
relative uncoupling of this circuit. These findings suggest a disruption in the feedback 
between the amygdala and anterior cingulated cortex. The areas within the anterior cingulate 
are most prominent in rostral parts, commonly associated with emotional conflict processing 
as opposed to a more cognitive caudal subdivision. The cognitive subdivision is part of a 
distributed attentional network. It maintains strong reciprocal interconnections with the lateral 
prefrontal cortex, parietal cortex and premotor and supplementary motor areas. The emotional 
subdivision is connected to the amygdala, periaqueductal grey, nucleus accumbens, 
hypothalamus, anterior insula, hippocampus and orbitofrontal cortex (Bush et al., 2000). The 
studies represent plausible explanations for the mentioned increased amygdala activity in 
carriers of the short 5-HTTLPR variants by decreased downregulation via the anterior 
cingulated cortex. The findings strongly suggest 5-HTTLPR-dependent variability in the 
interplay between cognitive and emotional processing.  
 
Anatomical studies in the primate brain reveal massive amygdala projections to the rostral 
anterior cingulate and efferent projections from the caudal anterior cingulate back to the 
amygdala (Paus, 2001). Convergent evidence suggests that these interactions constitute a 
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functional feedback circuitry that regulates amygdala processing of environmental adverse 
stimuli. Stimulation of the limbic prefrontal cortex inhibits amygdala function in primates 
(Stefanacci & Amaral, 2002), and medial prefrontal cortex neurons also exert an inhibitory 
influence on the amygdala (Maren & Quirk, 2004). Given the evidence that the rostral 
anterior cingulate modulates amygdala activity by inhibition, an uncoupling of the structures 
can explain the association between these areas, under a strong serotonergic influence, and 5-
HTTLPR variability. Reduced coupling would translate into altered feedback regulation of 
amygdala activity.  
 
The reviewed coupling between the amygdala and the ventromedial prefrontal cortex, which 
may participate in amygdala activity (Heinz et al., 2005), is most likely based on indirect 
anatomical interconnections. This assumption is based on the fact that direct connections 
between those structures are sparse, if they exist at all (Carmichael & Price, 1995; Ghashghaei 
& Barbas, 2002). Pezawas et al. (2005) speculate that the connection represents a 
compensatory mechanism for a primary regulatory loop involving the anterior cingulated 
cortex. In this case, over activation of the amygdala will lead to compensatory over activity in 
the ventromedial prefrontal cortex. The studies represent massive evidence which indicates 
several structures to be involved in the activation, inhibition, modulation and mediation of 
components involved in emotional perception and processing.  
 
The conceptual framework represents a profitable fundament to understand both structural 
and functional implications of altered 5-HTT function in emotional processing. 
Endophenotypes are basically found within limbic structures and different subdivisions of the 
prefrontal cortex, overlapping considerably with the structures known to be altered in major 
depression. Increased amygdala activation in carriers of short 5-HTTLPR variants reflects a 
direct or indirect increased sensitivity toward emotionally significant stimuli. The sensitivity 
will make these individuals emotionally labile. Decreased prefrontal downregulation 
represents altered functions in circuits important for the modulation and inhibition of 
emotional processing and will have implications for automatic regulation and further 
regulation of an affective state (Fig. 4). 
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Figure 4 illustrate predictions of increased 5-HTTLPR-dependent amygdala activation, and decreased frontal 5-
HTTLPR activation. Altered activation will have implications for all three aspects of emotional processing. 
Increased sensitivity and altered downregulation (green arrows) make individuals labile in association with 
emotional activation (red arrow). VLPFC = ventrolateral prefrontal cortex; DLPFC = dorsolateral prefrontal 
cortex; DMPFC = dorsomedial prefrontal cortex; OrbFC = orbitofrontal cortex; ACG = anterior cingulated 
gyrus.  
 
Under normal circumstances emotional activation, produced when presented with salient 
stimuli, will be downregulated. The model posits increased sensitivity in short 5-HTTLPR 
carriers to alter this down-regulating mechanism. Short 5-HTTLPR carriers are sensitive and 
labile when identifying negative emotional stimuli. The presented neuroimaging studies 
indicate that this sensitivity makes these individuals endangered to endurable functional and 
structural changes associated with depressive symptomatology.   
 
Objective 
By constructing a measure of cognitive control functioning containing both neutral and 
negative emotional categories, we can explore 5-HTTLPR-depended variability in cognitive 
functioning and emotional processing. The resolution in this measure has the potential to 
uncover specific 5-HTTLPR-dependent patterns associated with specific emotional categories 
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and represents an important supplement to contemporary studies which have been dominated 
by studies based on neuroimaging, reporting of life events, personality traits and 
symptomatology.   
 
The measure is based on the conceptual model and the reviewed findings which demonstrate 
that the 5-HTTLPR-dependent variability is linked to frontal- and limbic structures and the 
corresponding functions. Measures to assess cognitive control functions exist in many forms. 
Ideally, we want to cover all of Miyake et al.’s (2000) sub-components of executive 
functioning (updating, inhibition and shifting). The use of an n-back task was chosen based on 
that the procedure being considerably elaborated and known to activate the cingulated cortex 
and the frontal lobes (Owen, McMillan, Laird & Bullmore, 2005). The n-back task mainly 
covers information updating in Miyake et al.’s diversity but also involves aspects of inhibition 
as participants have to ignore irrelevant categories, and shifting as participants have to attend 
to more than one emotional category at the same time. The introduction has presented massive 
evidence that constitutes the rationale for using human emotional faces as stimuli for 
emotional activation (Breiter et al., 1996; Morris et al., 1996; Blair et al., 1999; DuBois et al., 
1999; Phillips et al., 1997, 2001; Wright et al., 2001; Davis & Whalen, 2001). 
 
Hypotheses 
The first question we want to answer is whether altering emotional stimuli will affect 
cognitive control functioning. Our hypothesis is that presenting potentially significant 
emotional stimuli will affect cognitive control functioning independent of 5-HTTLPR variant 
or sex.  
 
The second question we want to answer is whether the variation is 5-HTTLPR-dependent. 
Our hypothesis is that short 5-HTTLPR variants will be associated with increased sensitivity 
to negative emotional stimuli compared with long 5-HTTLPR carriers.  
 
We also want to investigate potential sex-specific effects as some studies show effects 
delimited to females, stronger among females and even sometimes the opposite pattern in 
males and females.   
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Methods and Materials 
Participants 
A total of 60 healthy Norwegian individuals, 34 females and 26 males (M age=32,8), 
screened according to the Structural Clinical Interview for DSM-IV, Axis I and II disorders 
(SCID I and SCID II). We also included background interviews to assess demographical 
information relevant to inclusion or as control variables. Pre-criteria for inclusion were 
individuals between 18 and 60 years, without organic brain disease, psychopharmacologic 
medication or alcohol/drug addiction, willing to accomplish a 3-4 hour session containing 
genotyping (blood sample), screening of symptomatology and neuropsychological testing. 
Participants received a 250 NOK favour. Two participants were excluded from the study 
based on screening procedures revealing DSM-IV criteria of an Actual Major Depressive 
Episode.  
 
The study is part of a project which applied to the Regional Ethics Committee and adheres to 
the Helsinki Convention. All data were collected and stored according to prescribed 
procedures fulfilling these standards.  
 
Genotyping 
The procedure for genotyping the triallelic 5-HTTLPR polymorphism located in the SLC6A4 
gene, coding the serotonin transporter protein (HTT), has been performed essentially as 
described in detail elsewhere (Gelernter, Kranzler & Cubells, 1997; Stein, Seedat & 
Gelernter, 2006). Briefly, genomic DNA was amplified by polymerase chain reaction (PCR) 
on a real-time fluorescence LightCycler instrument in a final volume of 20 ul using 
LightCycler Faststart DNA SYBR Green kit (Roche cat no 12239264001) with specific 
primers (0.5 uM) (Gelernter, Kranzler & Cubells, 1997) generating a long (L) 419 bp or a 
short (S) 375 bp PCR product depending on the presence of a 16 bp or a 14 bp sequence 
repeat, respectively, in the promoter region. Cycle conditions were the following: 10 min 
denaturation (95 oC), 45 cycles at 95 oC (10 s), 66 oC (10 s) and 72 oC (0 s). For the detection 
of an additional A/G single nucleotide polymorphism (SNP) that occurs within the L fragment 
(L allele), the PCR fragments were digested with 1 U MspI restriction enzyme (New England 
Biolabs, Beverly, Massachusetts) for 2 hour at 37 oC. The PCR fragments contain two 
obligatory MspI sites, whereas the A/G substitution creates an additional MspI site. Thus, a 
single PCR reaction and restriction digest followed by size fractioning on a gel provides 
classification of the S, LA and LG alleles. The triallelic classification was then reclassified into 
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a diallelic model, based on the level of 5-HTT gene expression as follows: LG/S, LG/LG and 
S/S participants were classified as S/S; LA/S and LA/LG participants were classified as L/S; 
and LA/LA participants were classified as L/L (Hu et al., 2006; Neumeister et al., 2006). 
 
A biobank was established at the Psychopharmacological Department at Diakonhjemmet 
Hospital, where the blood samples were implemented. The Clinical Chemical Department at 
Ullevål University Hospital conducted genotyping procedures using polymerase chain 
reaction (PCR). Extracted DNA and classification from Yale University School of Medicine, 
used in Walderhaug’s (2007) doctoral dissertation, were used as control samples.  
 
The Emo n-back 
To assess the implications of potentially emotional stimuli in measures of cognitive control 
functioning, we constructed an n-back paradigm containing emotional expressions in human 
faces. The paradigm was programmed using E-primes E-studio software. We showed 1000ms 
of sequential presentations of 360 pictures of sad, happy, fearful and neutral faces. A centred 
fixation point represented another thousand milliseconds’ stimulus interval. The stimuli were 
presented in 3 blocks of 120 trials, each containing 8 targets for each emotional category. 
Stimuli were selected from the material from validated images of facial expressions from The 
Karolinska Directed Emotional Faces (Lundqvist, Flykt & Öhmann, 1998). Images were set in 
black backgrounds and adjusted for borders and image resolution. We also included a practice 
procedure with “right”, “wrong” and “should have responded” feedback. The participants are 
instructed to respond each time the same facial expression, hence not the same face, are 
presented twice in a row (1-back). Outcome measures were percentage accuracy and reaction 
time in correct responses (Fig. 5). 
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Figure 5 illustrates the Emo n-back. Participants are presented with four emotional categories of facial 
expressions with a stimulus interval of 1000 ms. Another 1000 ms fixation point is presented between each 
image. The participants are instructed to respond each time the same facial expression, hence not the same face, 
is presented twice in a row.  
 
Control Variables 
The subscales Similarities (M=24,9) and Picture Completion (M=22,6) from WAIS III were 
used to detect potential group differences in general intelligence. The Beck Anxiety Inventory 
(M=3,3) and Beck Depression Inventory (M=4,6) were used to detect potential differences in 
actual symptomatology.  
 
Statistical Analyses 
Multivariate tests were conducted using Wilk’s Lamda (λ) as the most commonly reported 
statistics. The main reason for using λ is that the multivariate approach is less affected by 
violations of the sphericity assumption than the univariate alternatives (Pallant, 2001). A one-
way repeated measures ANOVA was conducted to compare emotional categories within the 
Emo n-back. Paired sample t-tests were conducted post hoc to evaluate the directions of the 
potential differences within the Emo n-back. A mixed between–within subject analysis of 
  30
variance was conducted to explore the impact of sex and genotype on accuracy in emotional 
categories as measured by the Emo n-back (emotional category × sex × 5-HTTLPR 
genotype). A two-way univariate ANOVA was conducted for each emotional category to 
investigate a potential specificity. A mixed between-within subject analyses of variance was 
used to compare the sad category to the neutral condition. 
  
Mixed between-within subject analyses was conducted post hoc to explore the implications of 
reaction time. The p-value to achieve statistical significance was set to the .05 level in all 
analyses. Effect size was evaluated according to Cohen (1988): Eta²=.01=small effect, Eta²= 
.06= moderate effect and Eta²=.14=large effect. 
 
Results 
Validating the Emo n-back 
A one-way repeated measures ANOVA was conducted to compare emotional categories 
within the Emo n-back. The means and standard deviations are presented in Table 1. There 
was a significant effect for category (Eta²=.75, λ=.25, F[3,59]=50.07, p<.0005). 
 
Descriptive Statistics for Emotional Categories within the Emo n-back._ 
__________________________________________________________ 
Emotional Category   N  Mean  SD___ 
Neutral    60  .8107  .17087 
Happy     60  .8963  .13288 
Fear     60  .7210  .16426 
Sad     60  .6697  .21002 
 
Table 1 shows number of participants, mean and standard deviation for emotional categories based on 
percentage accuracy in correct responses.  
 
Paired sample t-tests were conducted post hoc to evaluate the directions of the differences 
within the Emo n-back. All t-tests revealed statistically significant differences between 
categories. Accuracy was statistically decreased in the sad and fear compared to the neutral 
condition. There was also significantly increased accuracy when comparing neutral to happy 
and fear to sad. Neutral-fear (t[59]=5.540, p<.0005), neutral-sad (t[59]=6.038, p<.0005), 
neutral-happy (t[59]=-5.403, p<.0005) and fear-sad (t[59]=-2.555,  p=.013). 
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There were no correlations between reaction time and accuracy. This suggests an absence of 
speed-accuracy tradeoff effect, which would predict an association between faster responses 
and less correct responses. The decreased accuracy in negative compared with neutral stimuli 
is therefore not indicated by reaction time artifacts within the Emo n-back.   
 
Group Differences 
A mixed between-within subject analysis of variance was conducted to explore the impact of 
sex and genotype on accuracy in emotional categories as measured by the Emo n-back. 
Subjects were divided into three genotypes according to the triallelic division. In addition to 
the reported effect of category, multivariate tests revealed a statistically significant sex- 
category interaction effect, Eta²=.31, λ=.69, F[3,49]=7,21, p<.0005. There was also a 
statistically significant three-way interaction between category, sex and genotype, Eta²=.12, 
λ=.77, F(6,98)=2,23, p=.047 (Fig. 6).  
 
 
 
Figure 6 illustrate the results reported from the mixed between-within ANOVA. The figures show the three-way 
interaction between sex, category and genotype. The figures indicate that the genotype-dependent pattern for 
males and females are distinctively pronounced in the sad category.  
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A two-way univariate ANOVA was conducted for each emotional category to investigate the 
specificity of the three-way interaction indicated by the figures from the multivariate tests. 
These tests revealed an effect specific and restricted to the sad category Eta²=.15, 
F[2,51]=4.59, p=.015 (effect size for the neutral, happy and fear categories was respectively 
Eta²=.01, Eta²=.03 and Eta²=.02). It’s important to note that the original multivariate analyses 
are based on stricter criteria and represent stronger statistical power than this two-way 
univariate ANOVA.   
 
We also want to conduct a mixed between-within subject analysis of variance to compare the 
sad category to the neutral condition. Multivariate tests revealed a statistically significant sex- 
category interaction effect (Eta²=.21, λ=.79, F[1,51]=13,34, p=.001). There was a statistically 
significant three-way interaction between category, sex and genotype (Eta²=.19, λ=.81, 
F[2,51]=6,11, p=.004) (Fig. 7). 
 
 
 
Figure 7 illustrate the results from the comparison between the neutral and sad categories. The mixed between-
within ANOVA revealed a three-way interaction between category, sex and genotype. The short 5-HTTLPR 
variants demonstrate a distinct pattern for females.  
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There were no statistically significant effects of sex or genotype on BDI or BAI, indicating 
group differences in actual symptomatology linked to anxiety or depression, and no group 
differences in age or in general intelligence indicated by the raw scores from the subscales 
Similarities and Picture Completion from WAIS III.  
 
A post hoc mixed between-within subject analysis of variance was conducted to explore 
group differences in reaction time. The mixed between-within subject ANOVA revealed no 
statistically significant tree-way interaction effects between category, sex and genotype, but a 
statistically significant category-genotype interaction effect (Eta²=.14, λ=.73, F[6,98]=2,74, 
p=.017). There was also a marginal sex-genotype interaction effect (Eta²=.12, λ=.87, 
F[3,49]=2,25, p=.094). Comparing single emotional categories to the neutral condition 
revealed no statistically significant effects.  
 
Discussion 
Introducing the Emo n-back 
The introduction of the Emo n-back supports the hypothesis that the stimulus’ emotional 
content affects cognitive control functioning as assessed by an n-back procedure. Decreased 
accuracy in categories sad and fear, but increased accuracy in the happy category, compared 
with the neutral condition, indicate an effect restricted to the presentation of negative 
emotional categories. The sad emotional faces reveal the lowest accuracy, indicating sad 
emotional stimuli as the most difficult emotional category, and also significantly more 
difficult than the fear emotional category.  
 
Of Miyake et al.’s (2000) sub-components of executive functioning, the n-back procedure is 
probably linked to information updating and monitoring, but also involves aspects of 
inhibition as participants have to ignore irrelevant categories, and shifting as participants have 
to attend to more than one emotional category at the same time. The output from the Emo n-
back could also represent cognitive components not attended to, like perceptual differences 
between categories, priming effects or impact of commission errors within the Emo n- back. 
The indications from the Emo n-back need to be further explored and replicated to spot the 
nature of the paradigm and its outcome measures. Absent speed-accuracy effects indicate no 
reaction time-related artifacts within the Emo n-back, but do not outrun potential 5-HTTLPR-
dependent or gender specific patterns in reaction time linked to actual differences in cognitive 
and emotional processing.   
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Introducing the Emo n-back supports our hypothesis by demonstrating different emotional 
stimuli to play an important role in a behavioural measure of cognitive control functioning. 
The anatomical and conceptual correlates are indicated both in the reviewed studies and our 
conceptual framework, and are consistent with our predictions introducing the Emo n-back. 
Some of the results observed could conceivably be associated with circuitry which serves to 
regulate emotion. Negative emotional categories could represent more complex emotional and 
cognitive processing in the interplay between the identification of emotional significance, the 
production of an affective state and downregulation of the affective state.  
 
The 5-HTTLPR-Dependent Variability 
The analyses from the Emo n-back demonstrate statistically significant three-way interaction 
between category, sex and genotype and also an interaction between sex and emotional 
category within the Emo n-back. The findings accent the importance of taking sex into 
account as several studies indicate sex-specific effects (Brummett et al., 2007; Elley et al., 
2004; Kendler et al., 2005; Sjöberg et al., 2006; Uher & McGuffin et al., 2008).  
 
The three-way interaction is clearly linked to, and mostly pronounced when introducing sad 
human faces. Homozygote short 5-HTTLPR carriers have higher accuracy for both males and 
females compared with the homozygote long 5-HTTLPR carriers. The effect is not seen when 
presented with emotional expressions of fearful, neutral or happy faces but also indicates a 
different pattern for men and women in these categories. It’s important to note that our primal 
analyses take all categorical differences into account and most of all demonstrate different 
functional patterns. Heterozygote 5-HTTLPR carriers reveal an opposite pattern for men and 
women within the sad category but are not considered when comparing the homozygote 
variants.  
 
When we compared the sad category to the neutral category we saw a distinct pattern for short 
female 5-HTTLPR carries. Our hypotheses that short 5-HTTLPR variants are associated with 
increased sensitivity to negative emotional stimuli, compared to long 5-HTTLPR carries, 
seems to be sex specific. Female short 5-HTTLPR carries demonstrate better accuracy in the 
sad category compared to the neutral category indicating vigilance toward negative emotional 
stimuli. No distinct 5-HTTLPR dependent patterns are found within the fear category as 
measured by the Emo n-back. 
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Importantly, specific effects linked to the sad category are not predicted by the reported 
imaging studies, but are also found when presented to other negative emotional categories, 
like the fear emotional category (Munafò, Brown & Hariri, In Press). Beevers et al.’s (2007) 
behavioural reaction time measure also reported an attention bias restricted to anxious word 
stimuli, hence in a heterogenic inpatient group, when comparing long 5-HTTLPR carriers to 
carriers of one or two copies of short 5-HTTLPR variants. Exploring potential effects of 
reaction time within The Emo n-back did not reveal a specific effect of reaction time but a 
statistically significant 5-HTTLPR-dependent effect of the total differences between 
emotional categories.  
 
Operating with three 5-HTTLPR categories (S/S, L/S and L/L, based on the triallelic model), 
the separation of emotional categories, including accuracy and reaction time, and the 
consideration of sex may contribute to the more specific effects linked to sad emotional 
stimuli reported from the Emo n-back.  
 
Depression is more common among females than in males (Piccinelli & Wilkinson, 2000) and 
the impact of life events, as measured by interviews or self reports are stronger among 
females than in males (Silberg et al., 1999; Maciejewski, Prigerson & Mazure, 2001). We also 
know that there exists a considerable sex difference in serotonin neurotransmission 
(Cosgrove, Mazure & Staley, 2007). Our study indicates increased sensitivity towards 
negative emotional stimuli in female short 5-HTTLPR carriers and suggests mechanisms that 
may represent diatheses to depressive symptomatology by sensitivity that makes female short 
5-HTTLPR carriers emotionally labile. The results from the Emo n-back support sex specific 
findings by demonstrating a statistically significant category-sex-genotype interaction effect. 
The effects of sex should be further explored by matching the genotypes by sex-specific 
variables like the female menstrual cycle.   
 
Comparing emotional categories does not necessarily uncover 5-HTTLPR dependent 
differences in emotional activation. Recently, studies have pointed at the importance of 
considering the implications of phasic and tonic models of 5-HTTLPR-dependent emotional 
activation. The traditional phasic activation model posits that the presence of short 5-
HTTLPR variants represents the same baseline activation but differences linked to the degree 
of activation when presented with emotionally significant stimuli. Comparing the neutral 
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category to the sad category will only address phasic differences between these two 
conditions.  
 
The tonic model explains brain activity in terms of greater baseline activation. Apparent 
differences between emotional categories may be driven by differences in tonic absolute 
activation. A combination of tonic and phasic activation represents a third model. Different 5-
HTTLPR variants could have higher baseline activation and an additional increased reactivity 
to specific stimuli. The reviewed endophenotypic studies often rely on relative activation, in 
the form of differences between two task conditions, rather than on absolute activation values. 
 
Canli et al. (2006) reported, by using perfusion imaging, that short allele carriers have clearly 
higher amygdala activation at rest. The 5-HTTLPR-dependent activation and connectivity 
were not restricted to the amygdala but linked to a wide network of other regions. The 
observations support the assumption that 5-HTTLPR variability are driven by tonic activation 
and also that the activation modulates extensive domains in brain function, not restricted to 
emotional processing. Rao et al. (2007) also found 5-HTTLPR variations in resting brain 
functions in healthy individuals using perfusion fMRI during a resting state. Individuals 
homozygous for the short variant showed significantly increased cerebral blood flow (CBF) in 
the amygdala and decreased CBF in the ventromedial prefrontal cortex. The three-way 
interaction from the Emo n-back demonstrates differences between four emotional categories 
and can’t be explained by the tonic model alone. The observed 5-HTTLPR-dependent 
amygdala activation could also represent modulation from other brain regions, like inhibitory 
activity from frontal structures involved in downregulation of an affective state.  
 
“It is possible that the observed amygdala activation patterns reflect influences from other 
brain systems. We have no evidence for or against it and make no assumptions either way” 
(Turhan Canli, e-mail, 04.02.08). 
 
Based on our findings, we believe that amygdala-associated activation both affects and 
reflects activation from many brain regions and that these circuits represent functional 
systems involved in emotional perception and processing. The 5-HTTLPR-dependent deficits 
caused by tonic differences should be present independent of the stimulus’ emotional content 
and are not supported by our study. The Emo n-back will, on the other hand, not discover the 
existence of potential tonic plus phasic 5-HTTLPR-dependent difference between emotional 
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categories. Further studies should address this problem by including a fifth non-facial 
category as a neutral baseline. This could represent an indicator of tonic contribution to 
explain variance within the Emo n-back. Limitations in comparisons lie in the assumption that 
processing of different emotional categories and a neutral baseline share the same functional 
and structural properties.  
 
To assume emotional over activation directly to predict accuracy in a measure of cognitive 
control function is probably a simplification of the actual processes involved. This paper has 
demonstrated several structures and their interconnections to be involved in complex 
functional systems. The passage of serotonin in the brain and 5-HTTLPR variation has 
demonstrated that the net effect of 5-HTTLPR variants is best understood as a spectrum of 
different variants rather than functional and dysfunctional variants. The distinct pattern in the 
heterozygote 5-HTTLPR carriers supports this argument. Future studies should therefore treat 
genetic heterozygotes as potentially distinct functional variants.  
 
The accuracy for different categories within the Emo n-back does neither reveal dysfunctions 
in cognitive control function per se. Short 5-HTTLPR carriers actually show higher accuracy 
for both men and women demonstrating better cognitive control functioning when presented 
with sad human faces compared with homozygote long variants. The 5-HTTLPR variability in 
cognitive control function seems to reflect subprocesses involved in emotional processing, 
like sensitivity that increase the likelihood to produce an affective state.  More similar designs 
are needed to explore the reliability and nature of the reported findings.  
 
Some of the functional variants seem to represent diathesis for depressive symptomatology 
(Uher & McGuffin, 2008). The results from the Emo n-back indicate 5-HTTLPR variability, 
not better explained by cognitive deficits associated with depressive symptomatology, in basal 
cognitive and emotional processing. The stress-depression hypotheses linked to short 5-
HTTLPR carriers are also consistent with our study indicating 5-HTTLPR-dependent 
emotional processing. The different genotypes show distinct patterns in the way they process 
adverse environmental stimuli. Short female 5-HTTLPR carriers show a particular specific 
pattern suggesting sex-specific sensitivity towards negative stimuli.   
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Conclusion 
Introducing the Emo n-back represents an advantageous contribution in a field that until now 
have focused on endophenotypes, personality traits and symptomatology 
 
As measured by the Emo n-back, the role of serotonin in cognition seems to be sex-specific 
and linked to subcomponents involved in emotional processing. The Emo n-back reveal 
effects that are particularly pronounced when presented with a sad emotional category, 
indicating altered sex-genotype dependent processing linked to specific emotional content.  
 
In the context of an integrative model of emotional processing, the Emo n-back indicates 
mechanisms that might represent diatheses for depressive symptomatology by demonstrating 
different genotypes to reveal distinct patterns in the way they process adverse environmental 
stimuli. 
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